Advertisement
Singapore markets close in 5 hours 55 minutes
  • Straits Times Index

    3,276.66
    -23.38 (-0.71%)
     
  • Nikkei

    38,303.39
    -531.71 (-1.37%)
     
  • Hang Seng

    18,561.02
    +81.65 (+0.44%)
     
  • FTSE 100

    8,313.67
    +100.18 (+1.22%)
     
  • Bitcoin USD

    62,792.88
    -906.35 (-1.42%)
     
  • CMC Crypto 200

    1,301.47
    -63.66 (-4.66%)
     
  • S&P 500

    5,187.70
    +6.96 (+0.13%)
     
  • Dow

    38,884.26
    +31.99 (+0.08%)
     
  • Nasdaq

    16,332.56
    -16.69 (-0.10%)
     
  • Gold

    2,324.10
    -0.10 (-0.00%)
     
  • Crude Oil

    78.10
    -0.28 (-0.36%)
     
  • 10-Yr Bond

    4.4630
    -0.0260 (-0.58%)
     
  • FTSE Bursa Malaysia

    1,606.48
    +0.80 (+0.05%)
     
  • Jakarta Composite Index

    7,110.00
    -13.61 (-0.19%)
     
  • PSE Index

    6,582.94
    -35.64 (-0.54%)
     

Got $20? These 3 Healthcare Stocks Could Be Bargain Buys for 2022 and Beyond

Got $20? These 3 Healthcare Stocks Could Be Bargain Buys for 2022 and Beyond

On top of those pluses, these three companies all have a history of offering above-average dividends, making them solid long-term value bargains. Takeda is a Japanese biopharmaceutical company that focuses on gastroenterology, oncology, neuroscience, and rare diseases. The company's stock is up more than 9% this year, currently trading at just shy of $15.